Respiratory syncytial virus (RSV) is the principal pathogen associated with lower respiratory
tract illness (LRTI) in infants and children in the United States and in other industrialized …

Respiratory syncytial virus is the most important cause of lower respiratory tract infection in
infants and young children. RSV clinical disease varies from rhinitis and otitis media to …

Respiratory syncytial virus (RSV) is a single-stranded negative-sense RNA virus that is the
primary etiologic pathogen of bronchitis and pneumonia in infants and the elderly. Currently …

Respiratory syncytial virus causes a significant public health burden, particularly in very
young infants and the frail elderly. The legacy of enhanced RSV disease (ERD) from a …

Respiratorysyncytial virus (RSV) infection is at times associated with life-threatening lower
respiratory tract illness in infancy. Severe infection during the first year of life may be an …

Highlights•Maternal immunization provides a path to early infant protection against
RSV.•Structure-based engineering overcomes the biochemical challenges of the RSV F …

Respiratory syncytial virus (RSV) causes severe lower respiratory tract disease in infants,
young children, and the elderly. Efforts to develop satisfactory live or inactivated vaccines …

Respiratory syncytial virus (RSV) is a massive medical burden on a global scale. Infants,
children and the elderly represent the vulnerable populations. Currently there is no …

Respiratory syncytial virus (RSV) and human parainfluenza viruses (hPIVs) are leading
causes of viral lower respiratory tract illness in children and in high-risk adult populations …

Respiratory syncytial virus is one of the major respiratory pathogens for infants and
immunocompromized children. With the exception of young children, all the population has …